SpringerProtocols: Abstract: Genetic Markers in Psychiatric Genetics

Genetic Markers in Psychiatric Genetics

By: Thomas Bourgeron³, Bruno Giros⁴

Abstract

Full Text

Download PDF (404K)

Are the strategies for the identification of susceptibility genes in psychiatric diseases the same as those that have been used to successfully identify genes in monogenic diseases? How many cases, families, and markers are needed? These methodological questions are still a matter of debate for all complex traits, including psychiatric diseases. Furthermore, new technologies and methodologies for studying human genetics are emerging, and current protocols may rapidly become obsolete. This chapter presents an overview of the classical and novel gene identification strategies in complex diseases, and focuses on the problems encountered in psychiatric diseases. For each method, we discuss their relevance and what will probably be available in the near future. This review is written for clinicians close to the patients and molecular biologists close to the genes, who are not always familiar with the methods used to detect the link between individual genetic variations and the susceptibility to psychiatric diseases.

Affiliation(s): (3) Laboratoire d’fImmunogénétique Humaine, Institut Pasteur, 75724 Paris Cedex 15, France
(4) Department of Neurobiology and Psychiatry, Faculté de Médecine, INSERM U-513, 94000 CreitelCedex, France

Book Title: Psychiatric Genetics: Methods and Reviews

Series: Methods in Molecular Medicine | Volume: 77 | Pub. Date: Sep-10-2002 | Page Range: 63-98 | DOI: 10.1385/1-59259-348-8:63

Subject: Neuroscience

References

Download References

1.	Ishikawabrush Y., Powell J.F., Bolton P., Miller A.P., Francis F., Willard H.F., et al. (1997) Autism and multiple exostoses associated with an X-8 translocation occurring within the GRPR gene and 3′ to the Sdc2 gene. Hum. Mol. Genet. 6, 1241–1250.

2.	Gecz J., Barnett S., Liu J.J., Hollway G., Donnelly A., Eyre H., et al. (1999) Characterization of the human glutamate receptor subunit 3 gene (GRIA3), a candidate for bipolar disorder and nonspecific X-linked mental retardation. Genomics 62, 356–368.

3.	Vincent J.B., Herbrick J.A., Gurling H.M.D., Bolton P.F., Roberts W., and Scherer S.W. (2000) Identification of a novel gene on chromosomes 7q31 that is interrupted by a translocation breakpoint in an autistic individual. Am. J. Hum. Genet. 67, 510–514.

4.	Millar J.K., Wilson-Annan J.C., Anderson S., Christie S., Taylor M.S., Semple C., et al. (2000) Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum. Mol. Genet. 9, 1415–1423.

5.	Petek E., Windpassinger C., Vincent J.B., Cheung J., Boright A.P., Scherer S.W., et al. (2001) Disruption of a novel gene (immp21) by a breakpoint in 7q31 associated with tourette syndrome. Am. J. Hum. Genet. 68, 848–858.

6.	Papolos D.F., Faedda G.L., Veit S., Goldberg R., Morrow B., Kucherlapati R., et al. (1996) Bipolar spectrum disorders in patients diagnosed with velo-cardio-facial syndrome—does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder. Am. J. Psychiatry 153, 1541–1547.

7.	Bassett A.S., Hodgkinson K., Chow E.W.C., Correia S., Scutt L.E., and Weksberg R. (1998) 22q11 deletion syndrome in adults with schizophrenia. Am. J. Med. Genet. 81, 328–337. <Occurrence Type="DOI"><Handle>10.1002/(SICI)1096-8628(19980710)81:4<328::AID-AJMG10>3.0.CO;2-N</Handle></Occurrence>

8.	Thomas N.S., Sharp A.J., Browne C.E., Skuse D., Hardie C., and Dennis N.R. (1999) Xp deletions associated with autism in three females. Hum. Genet. 104, 43–48.

9.	Smith M., Filipek P.A., Wu C., Bocian M., Hakim S., Modahl C., et al. (2000) Analysis of a 1-megabase deletion in 15q22-q23 in an autistic patient: identification of candidate genes for autism and of homologous DNA segments in 15q22-q23 and 15q11-q13. Am. J. Med. Genet. 96, 765–770. <Occurrence Type="DOI"><Handle>10.1002/1096-8628(20001204)96:6<765::AID-AJMG13>3.0.CO;2-L</Handle></Occurrence>

10.	McGillivray B.C., Bassett A.S., Langlois S., Pantzar T., and Wood S. (1990) Familial 5q11.2-q13.3 segmental duplication cosegregating with multiple anomalies, including schizophrenia. Am. J. Med. Genet. 35, 10–13.

11.	Repetto G.R., White L.M., Bader P.J., Johnson D., and Knoll J.H.M. (1998) Interstitial duplications of chromosome region 15q11q13—clinical and molecular characterization. Am. J. Med. Genet. 79, 82–89. <Occurrence Type="DOI"><Handle>10.1002/(SICI)1096-8628(19980901)79:2<82::AID-AJMG2>3.0.CO;2-P</Handle></Occurrence>

12.	Knight S.J.L. and Flint J. (2000) Perfect endings: a review of subtelomeric probes and their use in clinical diagnosis. J. Med. Genet. 37, 401–409.

13.	Flint J., Wilkie A.O.M., Buckle V.J., Winter R.M., Holland A.J., and McDermid H.E. (1995) The detection of subtelomeric chromosomal rearrangements in idiopathic mental retardation. Nat. Genet. 9, 132–140.

14.	Knight S.J.L., Regan R., Nicod A., Horsley S.W., Kearney L., Homfray T., et al. (1999) Subtle chromosomal rearrangements in children with unexplained mental retardation. Lancet 354, 1676–1681. <Occurrence Type="DOI"><Handle>10.1016/S0140-6736(99)03070-6</Handle></Occurrence>

15.	Tanner M.M., Tirkkonen M., Kallioniemi A., Isola J., Kuukasjarvi T., Collins C., et al. (1996) Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer. Cancer Res. 56, 3441–3445.

16.	Pinkel L., Seagraves R., Sudar D., Clark S., Poole I., Kowbel D., et al. (1998) High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat. Genet. 20, 207–211.

17.	Leboyer M., Bellivier F., Nostenbertrand M., Jouvent R., Pauls D., and Mallet J. (1998) Psychiatric genetics—search for phenotypes. Trends Neurosci. 21, 102–105. <Occurrence Type="DOI"><Handle>10.1016/S0166-2236(97)01187-9</Handle></Occurrence>

18.	Leboyer M., Philippe A., Bouvard M., Guilloud-Bataille M., Bondoux D., Tabuteau F., et al. (1999) Whole blood serotonin and plasma beta-endorphin in autistic probands and their first-degree relatives. Biol. Psychiatry 45, 158–163. <Occurrence Type="DOI"><Handle>10.1016/S0006-3223(97)00532-5</Handle></Occurrence>

19.	Freedman R., Coon H., Mylesworsley M., Orrurtreger A., Olincy A., Davis A., et al. (1997) Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc. Natl. Acad. Sci. USA 94, 587–592.

20.	Brzustowicz L.M., Honer W.G., Chow E.W.C., Hogan J., Hodgkinson K., and Bassett A.S. (1997) Use of a quantitative trait to map a locus associated with severity of positive symptoms in familial schizophrenia to chromosome 6p. Am. J. Hum. Genet. 61, 1388–1396.

21.	Dib C., Faure S., Fizames C., Samson D., Drouot N., Vignal A., et al. (1996) A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 380, 152–154.

22.	Kruglyak L. and Nickerson D.A. (2001) Variation is the spice of life. Nat. Genet. 27, 234–236.

23.	Sachidanandam R., Weissman D., Schmidt S.C., Kakol J.M., Stein L.D., Mullikin J.C., et al. (2001) A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 409, 928–933.

24.	Kruglyak L. (1999) Prospects for whole-genome linkage disequilibrium mapping of common disease genes. Nat. Genet. 22, 139–144.

25.	Collins A., Lonjou C., and Morton N.E. (1999) Genetic epidemiology of single-nucleotide polymorphisms. Proc. Natl. Acad. Sci. USA 96, 15,173–15,177.

26.	Ott J. (2000) Predicting the range of linkage disequilibrium. Proc. Natl. Acad. Sci. USA 97, 2–3.

27.	Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N., et al. (1999) Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat. Genet. 22, 231–238.

28.	Jeffreys A.J., Ritchie A., and Neumann R. (2000) High resolution analysis of haplotype diversity and meiotic crossover in the human TAP2 recombination hotspot. Hum. Mol. Genet. 9, 725–733.

29.	Straub R.E., Maclean C.J., Oneill F.A., Burke J., Murphy B., Duke F., et al. (1995) A potential vulnerability locus for schizophrenia on chromosome 6p24-22—evidence of genetic heterogeneity. Nat. Genet. 11, 287–293.

30.	Adams L.J., Mitchell P.B., Fielder S.L., Rosso A., Donald J.A., and Schofield P.R. (1998) A susceptibility locus for bipolar affective disorder on chromosome 4q35. Am. J. Hum. Genet. 62, 1084–1091.

31.	Brzustowicz L.M., Hodgkinson K.A., Chow E.W.C., Honer W.G., and Bassett A.S. (2000) Location of a major susceptibility locus for familiar schizophrenia on chromosome 1q21-q22. Science 288, 678–682.

32.	Penrose L.S. (1935) The detection of automsomal linkage in data which consist of pairs of brother and sisters of unspecified parent age. Ann. Eugen. 6, 133–138.

33.	Olson J.M. and Wijsman E.M. (1993) Linkage between quantitative trait and marker loci: methods using all relative pairs. Genet. Epidemiol. 10, 87–102.

34.	Davis S. and Weeks D.E. (1997) Comparison of nonparametric statistics for detection of linkage in nuclear families—single-marker evaluation. Am. J. Hum. Genet. 61, 1431–1444.

35.	Hauser E.R. (1998) Genetic linkage analysis of complex genetic traits by using affected sibling pairs. Biometrics 54, 1238–1246.

36.	Risch N.J. (2000) Searching for genetic determinants in the new millennium. Nature 405, 847–856.

37.	Lander E. and Kruglyak L. (1995) Genetic dissection of complex traits—guidelines for interpreting and reporting linkage results. Nat. Genet. 11, 241–247.

38.	Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., Baldwin J., et al. (2001) Initial sequencing and analysis of the human genome. Nature 409, 860–921.

39.	Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G., et al. (2001) The sequence of the human genome. Science 291, 1304–1351.

40.	Wolfsberg T.G., McEntyre J., and Schuler G.D. (2001) Guide to the draft human genome. Nature 409, 824–826.

41.	Birney E., Bateman A., Clamp M.E., and Hubbard T.J. (2001) Mining the draft human genome. Nature 409, 827–828.

42.	Singh G.B. (2000) Computational approaches for gene identification. Methods Mol. Biol. 132, 351–364.

43.	Stoltenberg S.F. and Burmeister M. (2000) Recent progress in psychiatric genetics—some hope but no hype. Hum. Mol. Genet. 9, 927–935.

44.	Evans K.L., Muir W.J., Blackwood D.H., and Porteous D.J. (2001) Nuts and bolts of psychiatric genetics: building on the Human Genome Project. Trends Genet. 17, 35–40. <Occurrence Type="DOI"><Handle>10.1016/S0168-9525(00)02170-3</Handle></Occurrence>

45.	Paterson A.D., Sunohara G.A., and Kennedy J.L. (1999) Dopamine D4 receptor gene: novelty or nonsense? Neuropsychopharmacology 21, 3–16. <Occurrence Type="DOI"><Handle>10.1016/S0893-133X(98)00115-8</Handle></Occurrence>

46.	Veenstra-VanderWeele J., Anderson G.M., and Cook E.H. (2000) Pharmacogenetics and the serotonin system: initial studies and future directions. Eur. J. Pharmacol. 410, 165–181. <Occurrence Type="DOI"><Handle>10.1016/S0014-2999(00)00814-1</Handle></Occurrence>

47.	Collier D.A., Curran S., and Asherson P. (2000) Mission: Not impossible? Candidate gene studies in child psychiatric disorders. Mol. Psychiatry 5, 457–460.

48.	Trantino L.M. and Bucan M. (2000) Dissection of behavior and psychiatric disorders using the mouse as a model. Hum. Mol. Genet. 9, 953–965.

49.	Erdmann J., Nothen M.M., Shimronabarbanell D., Rietschel M., Albus M., Borrmann M., et al. (1996) The human serotonin 7 (5-HT7) receptor gene⊔enomic organization and systematic mutation screening in schizophrenia and bipolar affective disorder. Mol. Psychiatry 1, 392–397.

50.	Feng J.N., Sobell J.L., Heston L.L., Cook E.H., Goldman D., and Sommer S.S. (1998) Scanning of the dopamine D1 and D5 receptor genes by Ref in neuropsychiatric patients reveals a novel missense change at a highly conserved amino acid. Am. J. Med. Genet. 81, 172–178. <Occurrence Type="DOI"><Handle>10.1002/(SICI)1096-8628(19980328)81:2<172::AID-AJMG9>3.0.CO;2-Y</Handle></Occurrence>

51.	Hoogendoorn B., Norton N., Kirov G., Williams N., Hamshere M.L., Spurlock G., et al. (2000) Cheap, accurate and rapid allele frequency estimation of single nucleotide polymorphisms by primer extension and DHPLC in DNA pools. Hum. Genet. 107, 488–493.

52.	Spiegelman J.I., Mindrinos M.N., and Oefner P.J. (2000) Highaccuracy DNA sequence variation screening by DHPLC. Biotechniques 29, 1084–1090.

53.	Speight G., Turic D., Austin J., Hoogendoorn B., Cardno A.G., Jones L., et al. (2000) Comparative sequencing and association studies of aromatic L-amino acid decarboxylase in schizophrenia and bipolar disorder. Mol. Psychiatry 5, 327–331.

54.	Austin J., Hoogendoorn B., Buckland P., Speight G., Cardno A., Bowen T., et al. (2000) Comparative sequencing of the proneurotensin gene and association studies in schizophrenia. Mol. Psychiatry 5, 208–212.

55.	Halushka M.K., Fan J.B., Bentley K., Hsie L., Shen N.P., Weder A., et al. (1999) Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. Nat. Genet. 22, 239–247.

56.	Shi M.M. (2001) Enabling large-scale pharmacogenetic studies by high-throughput mutation detection and genotyping technologies. Clin. Chem. 47, 164–172.

57.	Ronaghi M. (2001) Pyrosequencing sheds light on DNA sequencing. Genome Res. 11, 3–11.

58.	Syvanen A.C., Aalto-Setala K., Harju L., Kontula K., and Soderlund H. (1990) A primer-guided nucleotide incorporation assay in the genotyping of apolipoprotein E. Genomics 8, 684–692. <Occurrence Type="DOI"><Handle>10.1016/0888-7543(90)90255-S</Handle></Occurrence>

59.	Lee L.G., Connell C.R., and Bloch W. (1993) Allelic discrimination by nick-translation PCR with fluorogenic probes. Nucleic Acids Res. 21, 3761–3766.

60.	Livak K.J. (1999) Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet. Anal. 14, 143–149.

61.	Tapp I., Malmberg L., Rennel E., Wik M., and Syvanen A.C. (2000) Homogeneous scoring of single-nucleotide polymorphisms: comparison of the 5′-nuclease TaqMan (R) assay and molecular beacon probes. Biotechniques 28, 732–738.

62.	Fors L., Lieder K.W., Vavra S.H., and Kwiatkowski R.W. (2000) Large-scale SNP scoring from unamplified genomic DNA. Pharmacogenomics 1, 219–229.

63.	Breen G., Harold D., Ralston S., Shaw D., and Clair D.S. (2000) Determining SNP allele frequencies in DNA pools. Biotechniques 28, 464–466.

64.	Haliassos A., Chomel J.C., Grandjouan S., Kruh J., Kaplan J.C., and Kitzis A. (1989) Detection of minority point mutations by modified PCR technique: a new approach for a sensitive diagnosis of tumor-progression markers. Nucleic Acids Res. 17, 8093–8099.

65.	Hacia J.G. (1999) Resequencing and mutational analysis using oligonucleotide microarrays. Nat. Genet. 21, 42–47.

66.	LaForge K.S., Shick V., Spangler R., Proudnikov D., Yuferov V., Lysov Y., et al. (2000) Detection of single nucleotide polymorphisms of the human mu opioid receptor gene by hybridization or single nucleotide extension on custom oligonucleotide gelpad microchips: potential in studies of addiction. Am. J. Med. Genet. 96, 604–615. <Occurrence Type="DOI"><Handle>10.1002/1096-8628(20001009)96:5<604::AID-AJMG5>3.0.CO;2-F</Handle></Occurrence>

67.	Hacia J.G., Fan J.B., Ryder O., Jin L., Edgemon K., Ghandour G., et al. (1999) Determination of ancestral alleles for human singlenucleotide polymorphisms using high-density oligonucleotide arrays. Nat. Genet. 22, 164–167.

68.	Kostrikis L.G., Tyagi S., Mhlanga M.M., Ho D.D., and Kramer F.R. (1998) Molecular beacons—spectral genotyping of human alleles. Science 279, 1228–1229.

69.	Nikiforov T.T., Rendle R.B., Goelet P., Rogers Y.H., Kotewicz M.L., Anderson S., et al. (1994) Genetic bit analysis—a solid phase method for typing single nucleotide polymorphisms. Nucleic Acids Res. 22, 4167–4176.

70.	Pastinen T., Kurg A., Metspalu A., Peltonen L., and Syvanen A.C. (1997) Minisequencing—a specific tool for DNA analysis and diagnostics on oligonucleotide arrays. Genome Res. 7, 606–614.

71.	Rossetti S., Englisch S., Bresin E., Pignatti P.F., and Turco A.E. (1997) Detection of mutations in human genes by a new rapid method—cleavage fragment length polymorphism analysis (CFLPA). Mol. Cell. Probes 11, 155–160.

72.	Oldenburg M.C. and Siebert M. (2000) New cleavase (R) fragment length polymorphism method improves the mutation detection assay. Biotechniques 28, 351–357.

73.	Ledford M., Friedman K.D., Hessner M.J., Moehlenkamp C., Williams T.M., and Larson R.S. (2000) A multi-site study for detection of the factor V (Leiden) mutation from genomic DNA using a homogeneous invader microtiter plate fluorescence resonance energy transfer (FRET) assay. J. Mol. Diag. 2, 97–104.

74.	Mein C.A., Barratt B.J., Dunn M.G., Siegmund T., Smith A.N., Esposito L., et al. (2000) Evaluation of single nucleotide polymorphism typing with invader on PCR amplicons and its automation. Genome Res. 10, 330–343.

75.	Hastbacka J., de la Chapelle A., Kaitila I., Sistonen P., Weaver A., and Lander E. (1992) Linkage disequilibrium mapping in isolated founder population diastrophic dysplasia in Finland. Nat. Genet. 2, 204–211.

76.	Laan M. and Paabo S. (1997) Demographic history and linkage disequilibrium in human populations. Nat. Genet. 17, 435–438.

77.	Lander E.S. and Schork N.J. (1994) Genetic dissection of complex traits. Science 265, 2037–2048.

78.	Bacanu S.A., Devlin. B., and Roeder K. (2000) The power of genomic control. Am. J. Hum. Genet. 66, 1933–1944.

79.	Spielman R.S., McGinnis R.E., and Ewens W.J. (1993) Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet. 52, 506–516.

80.	Spielman R.S. and Ewens W.J. (1996) The TDT and other familybased tests for linkage disequilibrium and association. Am. J. Hum. Genet. 59, 983–989.

81.	Spielman R.S. and Ewens W.J. (1998) A sibship test for linkage in the presence of association—the sib transmission/disequilibrium test. Am. J. Hum. Genet. 62, 450–458.

82.	Terwilliger J.D. and Ott J. (1992) A haplotype-based ‘haplotype relative risk’ approach to detection allelic associations. Hum. Hered. 42, 337–346.

83.	Heils A., Teufel A., Petri S., Stober G., Riederer P., Bengel D., et al. (1996) Allelic variations of human serotonin transporter gene expression. J. Neurochem. 66, 2621–2624.

84.	Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., et al. (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274, 1527–1531.

85.	Greenberg B.D., Tolliver T.J., Huang S.J., Li Q., Bengel D., and Murphy D.L. (1999) Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am. J. Med. Genet. 88, 83–87. <Occurrence Type="DOI"><Handle>10.1002/(SICI)1096-8628(19990205)88:1<83::AID-AJMG15>3.0.CO;2-0</Handle></Occurrence>

86.	Lachman H.M., Papolos D.F., Saito T., Yu Y.M., Szumlanski C.L., and Weinshilboum R.M. (1996) Human catechol—Omethyltransferase pharmacogenetics—description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6, 243–250.

87.	Cravchik A. and Gejman P.V. (1999) Functional analysis of the human D-5 dopamine receptor missense and nonsense variants: differences in dopamine binding affinities. Pharmacogenetics 9, 199–206.

88.	Mohn A.R., Gainetdinov R.R., Caron M.G., and Koller B.H. (1999) Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 98, 427–436. <Occurrence Type="DOI"><Handle>10.1016/S0092-8674(00)81972-8</Handle></Occurrence>

89.	Wolf C.R., Smith G., and Smith R.L. (2000) Science, medicine, and the future—pharmacogenetics. Br. Med. J. 320, 987–990.

90.	Roses A.D. (2000) Pharmacogenetics and the practice of medicine. Nature 405, 857–865.

91.	Coutts R.T. (1994) Polymorphism in the metabolism of drugs, including antidepressant drugs—comments on phenotyping. J. Psychiatry 19, 30–44.

92.	Arranz M.J., Munro J., Birkett J., Bolonna A., Mancama D., Sodhi M., et al. (2000) Pharmacogenetic prediction of clozapine response. Lancet 355, 1615–1616. <Occurrence Type="DOI"><Handle>10.1016/S0140-6736(00)02221-2</Handle></Occurrence>

Comments (Loading...)

Post comment/View all comments